BIOMAT Database Logo BIOMAT Database Logo

Trends in Alcoholic Fatty Liver Disease. 2019

Jinxiang Zhang, and Yong Lin, and Lanjing Zhang
Wuhan Union Hospital, Huazhong University of Science and Technology, Wuhan, China.

UI MeSH Term Description Entries
D005235 Fatty Liver, Alcoholic Lipid infiltration of the hepatic parenchymal cells that is due to ALCOHOL ABUSE. The fatty changes in the alcoholic fatty liver may be reversible, depending on the amounts of TRIGLYCERIDES accumulated. Alcoholic Fatty Liver,Alcoholic Steatohepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D065626 Non-alcoholic Fatty Liver Disease Fatty liver finding without excessive ALCOHOL CONSUMPTION. Fatty Liver, Nonalcoholic,NAFLD,Nonalcoholic Fatty Liver Disease,Nonalcoholic Steatohepatitis,Fatty Livers, Nonalcoholic,Liver, Nonalcoholic Fatty,Livers, Nonalcoholic Fatty,Non alcoholic Fatty Liver Disease,Nonalcoholic Fatty Liver,Nonalcoholic Fatty Livers,Nonalcoholic Steatohepatitides,Steatohepatitides, Nonalcoholic,Steatohepatitis, Nonalcoholic

Related Publications

Jinxiang Zhang, and Yong Lin, and Lanjing Zhang
Trends in Alcoholic Fatty Liver Disease-Reply.
September 2019, JAMA,
Jinxiang Zhang, and Yong Lin, and Lanjing Zhang
Global research trends in non-alcoholic fatty liver disease.
January 2023, Bratislavske lekarske listy,
Jinxiang Zhang, and Yong Lin, and Lanjing Zhang
Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
February 2019, Expert review of gastroenterology & hepatology,
Jinxiang Zhang, and Yong Lin, and Lanjing Zhang
Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.
August 2013, European journal of gastroenterology & hepatology,
Jinxiang Zhang, and Yong Lin, and Lanjing Zhang
Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease.
September 2018, Liver research,
Jinxiang Zhang, and Yong Lin, and Lanjing Zhang
Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease.
October 2020, Metabolism: clinical and experimental,
Jinxiang Zhang, and Yong Lin, and Lanjing Zhang
Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease.
May 2023, Journal of personalized medicine,
Jinxiang Zhang, and Yong Lin, and Lanjing Zhang
Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease.
January 2021, Frontiers in physiology,
Jinxiang Zhang, and Yong Lin, and Lanjing Zhang
Trends in statin utilisation in US adults with non-alcoholic fatty liver disease.
December 2021, Alimentary pharmacology & therapeutics,
Jinxiang Zhang, and Yong Lin, and Lanjing Zhang
Non-Alcoholic Fatty Liver Disease.
January 2017, Advances in experimental medicine and biology,
Copied contents to your clipboard!